Collegium Pharmaceutical (COLL) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Collegium Pharmaceutical (COLL) over the last 9 years, with Q4 2024 value amounting to $13.5 million.
- Collegium Pharmaceutical's Accumulated Depreciation & Amortization rose 3984.29% to $13.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $13.5 million, marking a year-over-year increase of 3984.29%. This contributed to the annual value of $13.5 million for FY2024, which is 3984.29% up from last year.
- Collegium Pharmaceutical's Accumulated Depreciation & Amortization amounted to $13.5 million in Q4 2024, which was up 3984.29% from $9.7 million recorded in Q4 2023.
- Collegium Pharmaceutical's 5-year Accumulated Depreciation & Amortization high stood at $13.5 million for Q4 2024, and its period low was $3.1 million during Q4 2020.
- Over the past 5 years, Collegium Pharmaceutical's median Accumulated Depreciation & Amortization value was $6.3 million (recorded in 2022), while the average stood at $7.5 million.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first surged by 3356.64% in 2020, then surged by 5366.49% in 2021.
- Quarter analysis of 5 years shows Collegium Pharmaceutical's Accumulated Depreciation & Amortization stood at $3.1 million in 2020, then surged by 53.66% to $4.7 million in 2021, then surged by 34.65% to $6.3 million in 2022, then soared by 53.06% to $9.7 million in 2023, then soared by 39.84% to $13.5 million in 2024.
- Its Accumulated Depreciation & Amortization stands at $13.5 million for Q4 2024, versus $9.7 million for Q4 2023 and $6.3 million for Q4 2022.